Biontech Founders Sahin and Türeci Say Goodbye: a Smart Decision

Spiegel

Lean Left

Factuality

Ownership

In the Corona crisis, Biontech was seen as a German hope for the whole world. Now the founders Uğur Şahin and Özlem Türeci leave the company, the share price crashes. What remains of the former flagship company?

Handelsblatt

Lean Right

Factuality

Ownership

The farewell of Ugur Sahin and Özlem Türeci at Biontech does insecure investors and pushes the stock. But their step stands for exactly the courageous entrepreneurial spirit that Germany needs now.

Frankfurter Allgemeine

Lean Right

Factuality

Ownership

The fact that Ugur Sahin and Özlem Türeci withdraw from the operational business of Biontech seems strange at first. But it is probably the next of many wise decisions of the research couple.

Welt

Lean Right

Factuality

Ownership

Ugur Sahin and Özlem Türeci leave the company. Investors wonder how much of Biontech is left without the architects – and why the two founders really leave? Now the real answer is obvious.

rnd.de

Factuality

Ownership

The two founders of Biontech, Uğur Şahin and Özlem Türeci, leave the company. Their next goal: AI-supported mRNA therapies. What remains of their work at Biontech?

finanzen100.de

Factuality

Ownership

The surprising withdrawal announcement of the Biontech founders Ugur Sahin and Özlem Türeci dramatically breaks the stock of the vaccine pioneer.